Fluconazole Susceptibility and Genotypic Analysis of Candida albicans from Clinical Sources in Nairobi, Kenya

被引：0
|
作者：
Chemutai, B. C. [1 ]
Korir, R. K. [1 ]
Mashedi, O. M. [1 ]
Gatumwa, E. [1 ]
Kangogo, M. C. [2 ]
机构：
[1] Kenya Govt Med Res Ctr, Mycol Lab, Nairobi, Kenya
[2] Jomo Kenyatta Univ, Dept Microbiol, Nairobi, Kenya
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷
关键词：
D O I：
10.1016/j.ijid.2008.05.746
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E277 / E278
页数：2
相关论文
共 50 条
  • [41] Fluconazole resistance is not associated with higher virulence in Candida albicans clinical isolates
    Schulz, B.
    Schmidt, A.
    Borg-von Zepelin, M.
    Ruhnke, M.
    MYCOSES, 2007, 50 (05) : 339 - 340
  • [42] Competitive Fitness of Fluconazole-Resistant Clinical Candida albicans Strains
    Popp, Christina
    Hampe, Irene A. I.
    Hertlein, Tobias
    Ohlsen, Knut
    Rogers, P. David
    Morschhaeuser, Joachim
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (07)
  • [43] Overcoming fluconazole resistance in Candida albicans clinical isolates with tetracyclic indoles
    Youngsaye, Willmen
    Dockendorff, Chris
    Vincent, Benjamin
    Hartland, Cathy L.
    Bittker, Joshua A.
    Dandapani, Sivaraman
    Palmer, Michelle
    Whitesell, Luke
    Lindquist, Susan
    Schreiber, Stuart L.
    Munoz, Benito
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (09) : 3362 - 3365
  • [44] Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients
    Kelly, SL
    Lamb, DC
    Kelly, DE
    Loeffler, J
    Einsele, H
    LANCET, 1996, 348 (9040): : 1523 - 1524
  • [45] Alkaloids from Tabernaemontana divaricata combined with fluconazole to overcome fluconazole resistance in Candida albicans
    Zhang, Yu
    Bai, Xue
    Yuwen, Huan-Sha
    Guo, Ling-Li
    Liu, Jian-Wen
    Hao, Xiao-Jiang
    BIOORGANIC CHEMISTRY, 2021, 107
  • [46] Chronic recurrent vulvovaginal candidosis caused by Candida albicans with reduced fluconazole susceptibility in vitro
    Dolgo-Saburova, J. V.
    Zhorzh, O. N.
    Vibornova, I. V.
    Shurpitskaya, O. A.
    Raush, E. R.
    Bogomolova, T. S.
    Klimko, N. N.
    MYCOSES, 2017, 60 : 231 - 231
  • [47] Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile
    Sadeghi, G.
    Ebrahimi-Rad, M.
    Mousavi, S. F.
    Shams-Ghahfarokhi, M.
    Razzaghi-Abyaneh, M.
    JOURNAL DE MYCOLOGIE MEDICALE, 2018, 28 (01): : 51 - 58
  • [48] Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice
    Khan, MA
    Khan, A
    Owais, M
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2006, 46 (01): : 63 - 69
  • [49] Decrease in Candida albicans strains with reduced susceptibility to fluconazole following changes in prescribing policies
    Lopez, J
    Pernot, C
    Aho, S
    Caillot, D
    Vagner, O
    Dalle, F
    Durnet-Archeray, MJ
    Chavanet, P
    Bonnin, A
    JOURNAL OF HOSPITAL INFECTION, 2001, 48 (02) : 122 - 128
  • [50] Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans
    Patterson, TF
    Kirkpatrick, WR
    Revankar, SG
    McAtee, RK
    Fothergill, AW
    McCarthy, DI
    Rinaldi, MG
    JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (12) : 3237 - 3239
12345